Want to see AU:SHL full AI Analyst Report?
SHL Stock Chart & Stats
AU$20.56
-AU$0.19(-0.67%)
At close: 4:00 PM EST
AU$20.56
-AU$0.19(-0.67%)
Day’s Range― - ―
52-Week RangeAU$18.26 - AU$29.24
Previous CloseN/A
Volume607.50K
Average Volume (3M)1.62M
Market Cap
AU$10.09B
Enterprise ValueAU$17.14B
Total Cash (Recent Filing)AU$557.12M
Total Debt (Recent Filing)AU$7.34B
Price to Earnings (P/E)18.4
Beta0.72
Next Earnings
Aug 20, 2026EPS Estimate
0.67Next Dividend Ex-DateN/A
Dividend Yield4.69%
Share Statistics
EPS (TTM)1.11
Shares Outstanding494,237,950
10 Day Avg. Volume1,694,025
30 Day Avg. Volume1,619,425
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.55
Price to Sales (P/S)1.34
P/FCF Ratio13.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$22.11Price Target Upside7.52% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.22
Revenue Forecast (FY)AU$10.95B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationSonic's materially higher free cash flow and strong operating-cash conversion provide durable funding for dividends, maintenance capex, automation and M&A integration. Reliable cash generation supports the firm's medium-term payout targets and optional sale-and-leaseback or buyback programs without eroding core operations.
Consistent Organic GrowthSustained ~5% organic expansion across multiple markets and service lines reflects underlying demand for diagnostics and imaging. Durable organic growth indicates resilient volumes, supporting steady revenue expansion and helping absorb fixed costs, which underpins multi-quarter margin and cash-flow stability.
Scale Via Acquisitions And Digital PlatformsProgress on large integrations (LADR) plus rapid adoption of proprietary digital pathology increases service scale, drives workflow efficiencies and differentiates offerings. Structural gains from platform migration and synergies from acquisitions can lift long-run margins and create higher barriers to entry in specialty diagnostics.
Bears Say
Higher Leverage From M&A And Property SpendElevated leverage from recent acquisitions and property investments reduces financial flexibility and raises interest exposure. Over the medium term this constrains discretionary spending and makes the company more sensitive to execution risks or FX swings while management targets investment-grade metrics and deleveraging.
U.S. Margin Pressure And RestructuringOngoing U.S. restructuring and weak organic growth in that market create persistent margin risk given its sizeable revenue share. Rationalisation can take quarters to realise benefits, and sustained underperformance in the U.S. would materially weigh on group profitability and returns over multiple reporting periods.
Working-capital Strain From Third-party Cyber IncidentProlonged billing/collections disruption increases receivables and temporary vendor advances, elevating net debt and working-capital volatility. Until fully resolved, this structural collection weakness limits cash conversion reliability and can delay expected benefits from revenue-collection improvements into subsequent fiscal years.
Sonic Healthcare Limited News
SHL FAQ
What was Sonic Healthcare Limited’s price range in the past 12 months?
Sonic Healthcare Limited lowest share price was AU$18.26 and its highest was AU$29.24 in the past 12 months.
What is Sonic Healthcare Limited’s market cap?
Sonic Healthcare Limited’s market cap is AU$10.09B.
When is Sonic Healthcare Limited’s upcoming earnings report date?
Sonic Healthcare Limited’s upcoming earnings report date is Aug 20, 2026 which is in 52 days.
How were Sonic Healthcare Limited’s earnings last quarter?
Sonic Healthcare Limited released its earnings results on Feb 18, 2026. The company reported AU$0.5 earnings per share for the quarter, missing the consensus estimate of AU$0.527 by -AU$0.027.
Is Sonic Healthcare Limited overvalued?
According to Wall Street analysts Sonic Healthcare Limited’s price is currently Undervalued.
Does Sonic Healthcare Limited pay dividends?
Sonic Healthcare Limited pays a Semiannually dividend of AU$0.45 which represents an annual dividend yield of 4.69%. See more information on Sonic Healthcare Limited dividends here
What is Sonic Healthcare Limited’s EPS estimate?
Sonic Healthcare Limited’s EPS estimate is 0.67.
How many shares outstanding does Sonic Healthcare Limited have?
Sonic Healthcare Limited has 494,237,950 shares outstanding.
What happened to Sonic Healthcare Limited’s price movement after its last earnings report?
Sonic Healthcare Limited reported an EPS of AU$0.5 in its last earnings report, missing expectations of AU$0.527. Following the earnings report the stock price went up 9.887%.
Which hedge fund is a major shareholder of Sonic Healthcare Limited?
Currently, no hedge funds are holding shares in AU:SHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonic Healthcare Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$22.11 (7.52% Upside)
AU$22.11 (7.52% Upside)
Blogger Sentiment
Bullish
AU:SHL Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.99%
12-Months-Change
Fundamentals
Return on Equity
6.39%
Trailing 12-Months
Asset Growth
10.74%
Trailing 12-Months
Company Description
Sonic Healthcare Limited
Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
SHL Stock 12 Month Forecast
Average Price Target
AU$22.11
▲(7.52% Upside)
Technical Analysis
Healius Limited
―
Genetic Signatures Ltd.
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Monash IVF Group Ltd
―
Options Prices
Currently, No data available
---









